Research & Innovation


Innovations to increase the reach and impact of immunization programmes are rapidly made available to all countries and communities.


Establish and strengthen capacity at all levels to identify priorities for innovation, and to create and manage innovation.

Develop new vaccines and technologies, and improve existing products and services for immunization programmes.

Evaluate promising innovations and scale up innovations, as appropriate, on the basis of the best available evidence.

Key areas of focus:

Needs-based innovation: Strengthen mechanisms to identify vaccine-related research and priorities for innovation according to community needs, particularly for underserved populations, and ensure that the priorities inform innovations in immunization products, services and practices.

New and improved products, services and practices: Accelerate the development of new vaccines, technologies and improved products, services and practices, while ensuring continued progress in the development of vaccines for priority targets, including HIV, TB, malaria and emerging infectious diseases.

Evidence for Implementation: Shorten the path to maximum vaccine impact by implementation and operational research and through evidence-informed decisions on policy and implementation based on sound evidence of needs, benefits and risks. Local innovation: Build local capacity to address programme challenges and maximize impact by cooperative creation, sourcing, adopting and scaling-up of innovations.

Application of the core principles:

People-centred. Innovations in products, services and practices will be client focused and address community and provider needs and preferences.

Country-owned. Countries will be able to identify, source and manage innovations in vaccines and immunization, including determining, documenting and communicating their priorities and identifying, evaluating and using local and global innovations. Country priorities will inform the global innovation agenda.

Partnership-based. Partners will devise ways to support the development, evaluation, use and sustainability of suitable immunization solutions, drawing on the complementary expertise of national and global stakeholders.

Data-guided. Evidence of unmet needs and the value of innovations in all aspects of immunization will be rigorously collected and shared to promote evidence-based research, development, execution and scale-up.